Healthcare Providers Reluctant to Prescribe HIV Drug despite New Recommendations

Healthcare Providers Reluctant to Prescribe HIV Drug despite New Recommendations

Truvada was approved in the early 2000s for the treatment of HIV for already infected people as the drug lowers the number of virus in the body and slows the progression of the disease.

The drug sought approval for pre-exposure prophylaxis or PrEP in July 2012, which meant the people who are not infected, but are at the risk, could take the drug as a preventative measure. The US Centers for Disease Control and Prevention (CDC) released recommendations for the drug in May 2014. The recommendations have suggested to increase the number of people taking the drug from 2,000 who are taking the drug now to a group of half a million people.

But for some reason, health care providers are not increasing the pace of recommending the drug to more people despite the drug's approval as a preventative measure. Also, there has been a vehement opposition from the gay community for the use of the drug.

Adam Zeboski is a 26-year-old HIV testing counselor in San Francisco and he made sexual relations with a man who was infected with HIV. He starts taking the drug in 2012, but he said that there is a lot of disapproval for the drug among his friends.

Zeboski said that people think that PrEP would turn them into a slut. He said that there were rumors about the drug two years ago that Truvada could be used before partying at night to seek protection against the transmission of HIV.

This is the major reason behind why health care providers are reluctant to prescribe the drug despite the CDC's new recommendations about the drug. It is very important for health care providers to overcome misunderstandings about the drug to ensure people at risk of getting infected from HIV are free from the lethal disease.

 

General: 
Companies: